{
    "Trade/Device Name(s)": [
        "EUROIMMUN Anti-ENA Pool ELISA (IgG)"
    ],
    "Submitter Information": "EUROIMMUN US INC.",
    "510(k) Number": "K112996",
    "Predicate Device Reference 510(k) Number(s)": [
        "K081104"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LJM"
    ],
    "Summary Letter Date": "March 28, 2013",
    "Summary Letter Received Date": "April 3, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5100"
    ],
    "Regulation Name(s)": [
        "Antinuclear Antibody Immunological Test System"
    ],
    "Analyte Class(es)": [
        "immunology",
        "autoimmune"
    ],
    "Analyte(s)": [
        "IgG antibodies against nuclear antigens (nRNP/Sm, Sm, SS-A (SS-A 60/Ro-52), SS-B, Scl-70, ribosomal P proteins)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Microwell plate reader capable of measuring OD at 450nm and at 620nm"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (ELISA)"
    ],
    "Methodologies": [
        "Qualitative enzyme immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for EUROIMMUN Anti-ENA Pool ELISA (IgG), a qualitative immunoassay for detection of IgG antibodies against nuclear antigens in serum as an aid in autoimmune disease diagnosis.",
    "Indications for Use Summary": "Qualitative determination of IgG class antibodies against nuclear antigens (nRNP/Sm, Sm, SS-A (SS-A 60/Ro-52), SS-B, Scl-70, ribosomal P proteins) in human serum to aid in the diagnosis of mixed connective tissue disease, systemic lupus erythematosus, Sj\u00f6gren's syndrome, and progressive systemic sclerosis in conjunction with other laboratory and clinical findings.",
    "fda_folder": "Immunology"
}